HYMAN CHARLES D - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 51 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HYMAN CHARLES D ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q3 2023$10,000
-65.5%
79,8000.0%0.00%
-50.0%
Q2 2023$29,000
-23.7%
79,8000.0%0.00%
-33.3%
Q1 2023$38,000
-5.0%
79,8000.0%0.00%0.0%
Q4 2022$40,000
-21.6%
79,8000.0%0.00%
-25.0%
Q3 2022$51,000
-19.0%
79,8000.0%0.00%
-20.0%
Q2 2022$63,000
-1.6%
79,8000.0%0.01%
+25.0%
Q1 2022$64,000
-21.0%
79,8000.0%0.00%
-20.0%
Q4 2021$81,000
-22.1%
79,8000.0%0.01%
-28.6%
Q3 2021$104,000
+67.7%
79,8000.0%0.01%
+75.0%
Q2 2021$62,000
-26.2%
79,8000.0%0.00%
-33.3%
Q1 2021$84,000
-22.9%
79,8000.0%0.01%
-33.3%
Q4 2020$109,000
+78.7%
79,8000.0%0.01%
+80.0%
Q3 2020$61,000
-1.6%
79,8000.0%0.01%
-16.7%
Q2 2020$62,000
+29.2%
79,8000.0%0.01%0.0%
Q1 2020$48,000
-73.5%
79,8000.0%0.01%
-66.7%
Q4 2019$181,000
+262.0%
79,8000.0%0.02%
+260.0%
Q3 2019$50,000
-26.5%
79,8000.0%0.01%
-28.6%
Q2 2019$68,000
-21.8%
79,8000.0%0.01%
-22.2%
Q1 2019$87,000
+85.1%
79,8000.0%0.01%
+50.0%
Q4 2018$47,000
-35.6%
79,8000.0%0.01%
-25.0%
Q3 2018$73,000
+108.6%
79,8000.0%0.01%
+100.0%
Q2 2018$35,000
-42.6%
79,8000.0%0.00%
-42.9%
Q1 2018$61,000
-34.4%
79,8000.0%0.01%
-36.4%
Q4 2017$93,000
-11.4%
79,8000.0%0.01%
-15.4%
Q3 2017$105,000
-22.2%
79,8000.0%0.01%
-23.5%
Q2 2017$135,000
-38.9%
79,8000.0%0.02%
-41.4%
Q1 2017$221,000
+190.8%
79,800
-11.1%
0.03%
+123.1%
Q4 2015$76,000
+2.7%
89,8000.0%0.01%0.0%
Q3 2015$74,000
+146.7%
89,800
+201.3%
0.01%
+160.0%
Q2 2015$30,000
+87.5%
29,8000.0%0.01%
+66.7%
Q1 2015$16,00029,8000.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 1,429,532$1,944,0000.61%
Boxer Capital, LLC 11,478,634$15,611,0000.50%
Vivo Capital, LLC 6,451,612$8,774,0000.39%
Philadelphia Financial Management of San Francisco, LLC 740,861$1,008,0000.26%
DCF Advisers, LLC 305,299$415,0000.17%
Main Street Financial Solutions, LLC 400,826$545,0000.11%
Platform Technology Partners 158,660$216,0000.10%
STALEY CAPITAL ADVISERS INC 600,000$816,0000.05%
MONECO Advisors, LLC 50,000$81,0000.04%
CCG WEALTH MANAGEMENT, LLC 30,000$41,0000.04%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders